United States Biotechnology & Medical Research

Matinas BioPharma Holdings Inc (MTNB)

Track

Track

Matinas BioPharma Holdings Inc has recorded no insider trading transactions within the past three months. The most recent activity occurred on August 21, 2020, when an insider purchased shares. Historical data shows a series of buy orders from various company officials between 2019 and 2020, with no subsequent selling reported.
Ticker: MTNB Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Matinas BioPharma Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
STERN ADAM K Non-Executive Director
Transaction date
Purchase
Price
266.31
Quantity 12,572 -13.2%
Value US$4,682,622
2.5
LEPORE PATRICK G Non-Executive Director
Transaction date
Purchase
Price
376.14
Quantity 86,878 -43.1%
Value US$2,399,732
2.7
Jabbour Jerome D President and CEO Executive Director
Transaction date
Purchase
Price
428.38
Quantity 71,334 +35.9%
Value US$4,459,514
3.1
STERN ADAM K Non-Executive Director
Transaction date
Purchase
Price
0.65
Quantity 10,000 +inf%
Value US$6,500
Kucinski Keith A Chief Financial Officer Officer
Transaction date
Purchase
Price
1.23
Quantity 58,000 +158.9%
Value US$71,160
Kucinski Keith A Chief Financial Officer Officer
Transaction date
Purchase
Price
1.20
Quantity 36,500 +inf%
Value US$43,807
LEPORE PATRICK G Non-Executive Director
Transaction date
Purchase
Price
1.06
Quantity 100,000 +50.0%
Value US$105,530
Ende Eric J Non-Executive Director
Transaction date
Purchase
Price
0.66
Quantity 20,000 +22.4%
Value US$13,200
Jabbour Jerome D President and CEO Executive Director
Transaction date
Purchase
Price
0.68
Quantity 14,650 +1.9%
Value US$9,975
Ende Eric J Non-Executive Director
Transaction date
Purchase
Price
0.68
Quantity 20,000 +28.9%
Value US$13,650
STERN ADAM K Non-Executive Director
Transaction date
Purchase
Price
0.70
Quantity 10,400 +1.3%
Value US$7,268
LEPORE PATRICK G Non-Executive Director
Transaction date
Purchase
Price
0.72
Quantity 100,000 +100.0%
Value US$71,850
3.1
STERN ADAM K
Transaction date
Purchase
Price
0.80
Quantity 15,000 +0.5%
Value US$12,000
3.1
STERN ADAM K
Transaction date
Purchase
Price
0.80
Quantity 20,000 +0.6%
Value US$15,998
2.7
Jabbour Jerome D President and CEO Executive Director
Transaction date
Purchase
Price
0.80
Quantity 12,487 +1.6%
Value US$9,980
3.1
STERN ADAM K
Transaction date
Purchase
Price
0.82
Quantity 15,000 +0.5%
Value US$12,300
3.1
STERN ADAM K
Transaction date
Purchase
Price
0.89
Quantity 20,000 +0.6%
Value US$17,800
3.1
STERN ADAM K
Transaction date
Purchase
Price
0.94
Quantity 80,000 +2.6%
Value US$75,200
3.1
STERN ADAM K
Transaction date
Purchase
Price
0.95
Quantity 150,000 +5.1%
Value US$142,500
0.6
CONRAD HERBERT J Non-Executive Director
Transaction date
Purchase
Price
0.96
Quantity 25,000 +16.9%
Value US$24,115
2.5
LEPORE PATRICK G Non-Executive Director
Transaction date
Purchase
Price
0.95
Quantity 100,000 +inf%
Value US$95,250
MANNINO RAPHAEL J Chief Scientific Officer
Transaction date
Purchase
Price
1.41
Quantity 5,000 +0.4%
Value US$7,050
Rongen Roelof Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.36
Quantity 5,000 +0.1%
Value US$6,800
STERN ADAM K
Transaction date
Purchase
Price
1.38
Quantity 50,000 +1.4%
Value US$69,000
STERN ADAM K
Transaction date
Purchase
Price
1.38
Quantity 50,000 +1.4%
Value US$69,000
Scibetta James S
Transaction date
Purchase
Price
1.29
Quantity 5,000 +1.2%
Value US$6,450
FERRARI STEFANO
Transaction date
Purchase
Price
1.24
Quantity 5,000 +2.5%
Value US$6,200
CONRAD HERBERT J
Transaction date
Purchase
Price
1.30
Quantity 100,000 +2.6%
Value US$130,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-08-24 2020-08-21 B Purchase
3.1
STERN ADAM K
Non-Executive Director
12,572 -13.2%
266.31
US$4,682,622 		12,572 -13.2% 266.31 US$4,682,622
2020-05-18 2020-05-14 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
86,878 -43.1%
376.14
US$2,399,732 		86,878 -43.1% 376.14 US$2,399,732
2020-03-18 2020-03-17 B Purchase
2.7
Jabbour Jerome D

President and CEO

Executive Director
71,334 +35.9%
428.38
US$4,459,514 		71,334 +35.9% 428.38 US$4,459,514
2020-03-18 2020-03-17 B Purchase
3.1
STERN ADAM K
Non-Executive Director
10,000 +inf%
0.65
US$6,500 		10,000 +inf% 0.65 US$6,500
2019-11-26 2019-11-25 B Purchase Kucinski Keith A

Chief Financial Officer

Officer
58,000 +158.9%
1.23
US$71,160 		58,000 +158.9% 1.23 US$71,160
2019-11-26 2019-11-22 B Purchase Kucinski Keith A

Chief Financial Officer

Officer
36,500 +inf%
1.20
US$43,807 		36,500 +inf% 1.20 US$43,807
2019-11-19 2019-11-15 B Purchase LEPORE PATRICK G Non-Executive Director
100,000 +50.0%
1.06
US$105,530 		100,000 +50.0% 1.06 US$105,530
2019-08-22 2019-08-20 B Purchase Ende Eric J Non-Executive Director
20,000 +22.4%
0.66
US$13,200 		20,000 +22.4% 0.66 US$13,200
2019-08-21 2019-08-19 B Purchase Jabbour Jerome D

President and CEO

Executive Director
14,650 +1.9%
0.68
US$9,975 		14,650 +1.9% 0.68 US$9,975
2019-08-21 2019-08-19 B Purchase Ende Eric J Non-Executive Director
20,000 +28.9%
0.68
US$13,650 		20,000 +28.9% 0.68 US$13,650
2019-08-21 2019-08-19 B Purchase STERN ADAM K Non-Executive Director
10,400 +1.3%
0.70
US$7,268 		10,400 +1.3% 0.70 US$7,268
2019-08-20 2019-08-16 B Purchase LEPORE PATRICK G Non-Executive Director
100,000 +100.0%
0.72
US$71,850 		100,000 +100.0% 0.72 US$71,850
2019-06-18 2019-06-14 B Purchase
3.1
STERN ADAM K
15,000 +0.5%
0.80
US$12,000 		15,000 +0.5% 0.80 US$12,000
2019-06-13 2019-06-12 B Purchase
3.1
STERN ADAM K
20,000 +0.6%
0.80
US$15,998 		20,000 +0.6% 0.80 US$15,998
2019-06-13 2019-06-12 B Purchase
2.7
Jabbour Jerome D

President and CEO

Executive Director
12,487 +1.6%
0.80
US$9,980 		12,487 +1.6% 0.80 US$9,980
2019-06-11 2019-06-10 B Purchase
3.1
STERN ADAM K
15,000 +0.5%
0.82
US$12,300 		15,000 +0.5% 0.82 US$12,300
2019-06-10 2019-06-07 B Purchase
3.1
STERN ADAM K
20,000 +0.6%
0.89
US$17,800 		20,000 +0.6% 0.89 US$17,800
2019-06-03 2019-05-31 B Purchase
3.1
STERN ADAM K
80,000 +2.6%
0.94
US$75,200 		80,000 +2.6% 0.94 US$75,200
2019-05-20 2019-05-16 B Purchase
3.1
STERN ADAM K
150,000 +5.1%
0.95
US$142,500 		150,000 +5.1% 0.95 US$142,500
2019-05-20 2019-05-16 B Purchase
0.6
CONRAD HERBERT J
Non-Executive Director
25,000 +16.9%
0.96
US$24,115 		25,000 +16.9% 0.96 US$24,115
2019-05-20 2019-05-16 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
100,000 +inf%
0.95
US$95,250 		100,000 +inf% 0.95 US$95,250
2017-09-15 2017-09-11 B Purchase MANNINO RAPHAEL J

Chief Scientific Officer
5,000 +0.4%
1.41
US$7,050 		5,000 +0.4% 1.41 US$7,050
2017-09-11 2017-09-08 B Purchase Rongen Roelof

Chief Executive Officer

Executive Director
5,000 +0.1%
1.36
US$6,800 		5,000 +0.1% 1.36 US$6,800
2017-09-11 2017-09-08 B Purchase STERN ADAM K
50,000 +1.4%
1.38
US$69,000 		50,000 +1.4% 1.38 US$69,000
2017-09-11 2017-09-07 B Purchase STERN ADAM K
50,000 +1.4%
1.38
US$69,000 		50,000 +1.4% 1.38 US$69,000
2017-09-07 2017-09-07 B Purchase Scibetta James S
5,000 +1.2%
1.29
US$6,450 		5,000 +1.2% 1.29 US$6,450
2017-09-07 2017-09-07 B Purchase FERRARI STEFANO
5,000 +2.5%
1.24
US$6,200 		5,000 +2.5% 1.24 US$6,200
2017-09-07 2017-09-07 B Purchase CONRAD HERBERT J
100,000 +2.6%
1.30
US$130,000 		100,000 +2.6% 1.30 US$130,000
Explore more

More insider trading research around Matinas BioPharma Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America